Robert Matthew Lutz Strongbridge Biopharma PLC (SBBP) insider trading activity

Robert Matthew Lutz is Chief Financial Officer of Strongbridge Biopharma plc. Currently has a direct ownership of 181,333 shares of SBBP, which is worth approximately $362,666. The most recent transaction as insider was on Feb 22, 2021, when has been sold 6,978 shares (Ordinary Shares) at a price of $3.62 per share, resulting in proceeds of $25,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 181K

0% 3M change

0% 12M change

Total Value Held $362,666

Robert Matthew Lutz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 22 2021	SELL Payment of exercise price or tax liability	$25,260 $3.62 p/Share	6,978 Reduced 3.71%	181,333 Ordinary Shares
Jan 07 2021	BUY Grant, award, or other acquisition	-	147,500 Added 43.92%	188,311 Ordinary Shares

Also insider at

IBIO

iBio, Inc. Healthcare

Officer

SVRA

Savara Inc Healthcare

Chief Operating Officer

RML